Company / Capital Returned to Shareholders
GYRE THERAPEUTICS, INC. Capital Returned to Shareholders History
FY2022-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$45.0M
FY2022
5-year range
$45.0M / $45.0M
FY2022-FY2022
Trend
-
vs FY2021
Sector context
#31 of 52
Health Care
What the data says
At $45M, GYRE THERAPEUTICS, INC.'s capital returned to shareholders ranks #31 of 52 in the Health Care sector.
Based on SEC 10-K filings.
$45M in FY2022.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#31 of 52 in Health CareTop 60% of 52This company $45.0M Sector average $1.3B
▼
-96.6% below sector average
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $45.0M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026